IGG4 RELATED DISEASE
Clinical trials for IGG4 RELATED DISEASE explained in plain language.
Never miss a new study
Get alerted when new IGG4 RELATED DISEASE trials appear
Sign up with your email to follow new studies for IGG4 RELATED DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New 'Living Drug' trial targets rare, debilitating autoimmune disease
Disease control Recruiting nowThis study is testing a new type of personalized immune cell therapy, called CAR-T cells, for adults with a chronic inflammatory condition called IgG4-related disease that has come back or not improved after standard treatments. The main goals are to see if the treatment is safe …
Matched conditions: IGG4 RELATED DISEASE
Phase: PHASE2 • Sponsor: Chinese PLA General Hospital • Aim: Disease control
Last updated Apr 04, 2026 05:06 UTC
-
New drug tested to shrink swollen glands in rare disease
Disease control Recruiting nowThis study is testing if a drug called efgartigimod can reduce swelling in the tear glands, salivary glands, or pancreas of adults with IgG4-related disease. Participants will receive weekly injections for up to 12 weeks and have regular checkups and scans to see if the treatment…
Matched conditions: IGG4 RELATED DISEASE
Phase: PHASE2 • Sponsor: Stanford University • Aim: Disease control
Last updated Apr 03, 2026 14:43 UTC
-
New drug combo trial aims to tame mysterious autoimmune disease
Disease control Recruiting nowThis study is testing if adding a medication called lenalidomide to the standard steroid treatment works better for people with active IgG4-Related Disease (IgG4-RD). It will involve about 200 adults to see if the combination lowers the chance of the disease flaring up again over…
Matched conditions: IGG4 RELATED DISEASE
Phase: PHASE2, PHASE3 • Sponsor: Peking Union Medical College Hospital • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
Donor cells tested to fight mysterious autoimmune disease
Disease control Recruiting nowThis early-stage study is testing a new cell therapy called ACE1831 for people with active IgG4-Related Disease (IgG4-RD), a condition where the immune system attacks the body's own tissues. The therapy uses immune cells (gamma delta T cells) from healthy donors. Researchers will…
Matched conditions: IGG4 RELATED DISEASE
Phase: PHASE1, PHASE2 • Sponsor: Acepodia Biotech, Inc. • Aim: Disease control
Last updated Mar 20, 2026 14:48 UTC